Tourmaline Bio Revenue and Competitors
Estimated Revenue & Valuation
- Tourmaline Bio's estimated annual revenue is currently $15.3M per year.
- Tourmaline Bio's estimated revenue per employee is $155,000
Employee Data
- Tourmaline Bio has 99 Employees.
- Tourmaline Bio grew their employee count by 68% last year.
Tourmaline Bio's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Chief Financial Officer & Treasurer | Reveal Email/Phone |
3 | Chief Business Officer and General Counsel | Reveal Email/Phone |
4 | SVP Product Development | Reveal Email/Phone |
5 | VP - Head Medical Affairs | Reveal Email/Phone |
6 | SVP, Head Quality | Reveal Email/Phone |
7 | Head IT | Reveal Email/Phone |
8 | SVP, Medical Research | Reveal Email/Phone |
9 | VP, People, Culture and Compliance | Reveal Email/Phone |
10 | VP, Head Pharmacovigilance | Reveal Email/Phone |
Tourmaline Bio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.6M | 4 | 0% | N/A | N/A |
#2 | $3.7M | 24 | 41% | $44M | N/A |
#3 | $6.2M | 40 | -7% | N/A | N/A |
#4 | $42M | 271 | -1% | N/A | N/A |
#5 | $12.7M | 82 | 0% | $10M | N/A |
#6 | $2.5M | 16 | 0% | N/A | N/A |
#7 | $7.5M | 45 | 0% | $51.6M | N/A |
#8 | $0.2M | 1 | -50% | N/A | N/A |
#9 | $4.3M | 26 | -16% | $3.3M | N/A |
#10 | $3.7M | 24 | 4% | N/A | N/A |
What Is Tourmaline Bio?
Tourmaline is a late-stage clinical biotechnology company driven by our mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune and inflammatory diseases. In doing so, we seek to develop assets medicines that have the potential to establish new standards-of-care in areas of high unmet medical need.
keywords:N/AN/A
Total Funding
99
Number of Employees
$15.3M
Revenue (est)
68%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $14.4M | 99 | 15% | N/A |
#2 | $15M | 99 | 13% | $2.2B |
#3 | $14.4M | 99 | 29% | N/A |
#4 | $14.4M | 99 | -6% | N/A |
#5 | $15M | 99 | 13% | N/A |